SKU 072117Ethiqa XR buprenorphine ExtendedRele
State & local contract award Virginia Awarded
- Contract number
- A236_P0357296
- Awardee
- COVETRUS NORTH AMERICA
- Contracting organization
- Virginia Commonwealth University
- Cumulative value
- $410.00
About this award
Covetrus North America has been awarded a contract by Virginia Commonwealth University (VCU) effective September 22, 2026, for the supply of pharmaceutical products to support VCU Procurement operations. The contract is valued at $410 and covers delivery of Ethiqa XR buprenorphine extended-release medication, with one unit procured at a unit price of $410. Virginia Commonwealth University serves as the contracting organization and place of performance for this award.
This procurement represents a single-line-item purchase of a controlled pharmaceutical substance for delivery to VCU's procurement department in the Commonwealth of Virginia. The contract award reflects VCU's selection of Covetrus North America as the prime contractor for this specialized medical supply requirement. No specific contract performance period beyond the award date of September 22, 2026, is indicated in the available contract documentation.
Line items
| Item | Total |
|---|---|
| SKU 072117Ethiqa XR buprenorphine ExtendedRele | $410.00 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A236_P0357296?
Contract A236_P0357296 was awarded to COVETRUS NORTH AMERICA by Virginia Commonwealth University on September 22, 2026.
How much is contract A236_P0357296 worth?
Its cumulative value is $410.00.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award